Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alma is an Israeli medical cannabis company dedicated to providing high-quality, standardized cannabis-based therapeutic products for patients. The company focuses on the cultivation, processing, and distribution of medical-grade cannabis flowers and oils tailored to specific clinical needs. By leveraging advanced agricultural techniques and pharmaceutical-grade manufacturing standards, Alma ensures consistent cannabinoid profiles across its product lines. Their portfolio is designed to address a wide range of indications, including chronic pain, neurological disorders, and psychiatric conditions. Alma operates within a strictly regulated framework to deliver safe and effective alternatives to traditional pharmacotherapy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alma Cannabis.